Prognostic value of baseline and early changes of circulating-free (cf) and circulating tumor (ct) DNA in the neoadjuvant (NA) setting of early stage colon cancer (CC).

Authors

null

Giacomo Bregni

Institut Jules Bordet-Université Libre de Bruxelles (ULB), Brussels, Belgium

Giacomo Bregni , Chiara Senti , Caroline Vandeputte , Elena Acedo Reina , Paraskevas Gkolfakis , Jean-Luc Van Laethem , Philippe Vergauwe , Marc Van Den Eynde , Jos Janssens , Gauthier Demolin , Stephane Holbrechts , Marylene Clausse , Thierry De Grez , Lionel A. D'Hondt , Karen Paula Geboes , Tatiana Besse-Hammer , Francoise Rothe , Patrick Flamen , Alain Hendlisz , Francesco Sclafani

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2021 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Gastrointestinal Cancer—Colorectal and Anal

Track

Gastrointestinal Cancer—Colorectal and Anal

Sub Track

Colorectal Cancer - Neo-Adjuvant/Adjuvant

Citation

J Clin Oncol 39, 2021 (suppl 15; abstr 3600)

DOI

10.1200/JCO.2021.39.15_suppl.3600

Abstract #

3600

Poster Bd #

Online Only

Abstract Disclosures

Similar Posters

First Author: Richard Francis Dunne

First Author: Frank A. Sinicrope

Poster

2020 Gastrointestinal Cancers Symposium

Circulating tumor DNA-based decision for adjuvant treatment in colon cancer stage II evaluation: (CIRCULATE-trial) AIO-KRK-0217.

Circulating tumor DNA-based decision for adjuvant treatment in colon cancer stage II evaluation: (CIRCULATE-trial) AIO-KRK-0217.

First Author: Gunnar Folprecht